| A comprehensive review on MAPK: a promising therapeutic target in cancer C Braicu, M Buse, C Busuioc, R Drula, D Gulei, L Raduly, A Rusu, A Irimie, ... Cancers 11 (10), 1618, 2019 | 690 | 2019 |
| Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression C Braicu, R Buiga, R Cojocneanu, M Buse, L Raduly, LA Pop, S Chira, ... Journal of Experimental & Clinical Cancer Research 38, 1-17, 2019 | 41 | 2019 |
| The relevance of mass spectrometry analysis for personalized medicine through its successful application in cancer “Omics” CA Ciocan-Cartita, A Jurj, M Buse, D Gulei, C Braicu, L Raduly, ... International Journal of Molecular Sciences 20 (10), 2576, 2019 | 37 | 2019 |
| Gold nanorods: From anisotropy to opportunity. An evolution update A Onaciu, C Braicu, AA Zimta, A Moldovan, R Stiufiuc, M Buse, C Ciocan, ... Nanomedicine 14 (9), 1203-1226, 2019 | 36 | 2019 |
| Solid plasmonic substrates for breast cancer detection by means of SERS analysis of blood plasma GF Știufiuc, V Toma, M Buse, R Mărginean, G Morar-Bolba, B Culic, ... Nanomaterials 10 (6), 1212, 2020 | 27 | 2020 |
| New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells CA Ciocan-Cartita, A Jurj, O Zanoaga, R Cojocneanu, LA Pop, ... Journal of Experimental & Clinical Cancer Research 39, 1-16, 2020 | 22 | 2020 |
| Approach to the adult acute lymphoblastic leukemia patient V Sas, V Moisoiu, P Teodorescu, S Tranca, L Pop, S Iluta, S Pasca, ... Journal of Clinical Medicine 8 (8), 1175, 2019 | 22 | 2019 |
| Decoding the emerging patterns exhibited in non-coding RNAs characteristic of lung cancer with regard to their clinical significance L Sonea, M Buse, D Gulei, A Onaciu, I Simon, C Braicu, ... Current Genomics 19 (4), 258-278, 2018 | 19 | 2018 |
| Gene expression patterns unveil new insights in papillary thyroid cancer M Saftencu, C Braicu, R Cojocneanu, M Buse, A Irimie, D Piciu, ... Medicina 55 (8), 500, 2019 | 15 | 2019 |
| Critical Analysis of Genome-Wide Association Studies: Triple Negative Breast Cancer Quae Exempli Causa MA Jurj, M Buse, AA Zimta, A Paradiso, SS Korban, LA Pop, ... International journal of molecular sciences 21 (16), 5835, 2020 | 12 | 2020 |
| A comprehensive review on MAPK: a promising therapeutic target in cancer. Cancers (Basel) 11: 1618 C Braicu, M Buse, C Busuioc, R Drula, D Gulei, L Raduly, A Rusu, A Irimie, ... | 12 | 2019 |
| A comprehensive review on MAPK: a promising therapeutic target in cancer. Cancers. 2019; 11 (10): 1618 C Braicu, M Buse, C Busuioc, R Drula, D Gulei, L Raduly, A Rusu, A Irimie, ... | 12 | |
| Transforming growth factor β‐mediated micromechanics modulates disease progression in primary myelofibrosis P Teodorescu, S Pasca, A Jurj, G Gafencu, JP Joelsson, S Selicean, ... Journal of Cellular and Molecular Medicine 24 (19), 11100-11110, 2020 | 11 | 2020 |
| The shifting landscape of genetic alterations separating endometriosis and ovarian endometrioid carcinoma AI Gaia-Oltean, LA Pop, RM Cojocneanu, M Buse, AA Zimta, P Kubelac, ... American Journal of Cancer Research 11 (4), 1754, 2021 | 8 | 2021 |
| Literature review on the feasibility of laparoscopic partial nephrectomy for renal cancer during pregnancy: a propos of a case B Petrut, M Hogea, T Tat, M Buse, V Schitcu, Z Sparchez J BUON 23 (4), 872-876, 2018 | 5 | 2018 |
| A comprehensive review on MAPK: a promising therapeutic target in cancer. Cancers 2019; 11: 1618 C Braicu, M Buse, C Busuioc, R Drula, D Gulei, L Raduly, A Rusu, A Irimie, ... | 5 | |
| The foundation of personalized medicine is the establishment of biobanks and their standardization L Policiuc, M Buse, D Gulei, AA Zimta, C Braicu, AI Irimie, ... Journal of BUON 23 (3), 550-560, 2018 | 4 | 2018 |
| A comprehensive review on MAPK: a promising therapeutic target in cancer. Cancers (Basel). 2019; 11 (10) C Braicu, M Buse, C Busuioc, R Drula, D Gulei, L Raduly, A Rusu, A Irimie, ... Epub 2019/10/28. https://doi. org/10.3390/cancers11101618 PMID: 31652660, 0 | 3 | |
| A comprehensive review on MAPK: a promising therapeutic target in cancer. Cancers (Basel). 2019; 11: 1618 C Braicu, M Buse, C Busuioc, R Drula, D Gulei, L Raduly, A Rusu, A Irimie, ... | 3 | |
| Cancer Chemotherapy, Bioactive Compounds, and Immunotherapy E Fischer-Fodor, AA Zimta, M Buse, IB Neagoe Functional Lipid Nanosystems in Cancer, 45-87, 2021 | | 2021 |
